tiprankstipranks
Trending News
More News >
NovaBridge Biosciences (NBP)
NASDAQ:NBP
US Market

NovaBridge Biosciences (NBP) Ratios

Compare
424 Followers

NovaBridge Biosciences Ratios

NBP's free cash flow for Q3 2025 was ¥0.00. For the 2025 fiscal year, NBP's free cash flow was decreased by ¥ and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Dec 23Mar 23Dec 21
Liquidity Ratios
Current Ratio
14.47 20.90 5.67 5.50 7.66
Quick Ratio
14.47 20.90 5.60 5.62 7.66
Cash Ratio
14.17 8.07 5.20 4.87 5.65
Solvency Ratio
-0.49 -13.92 -1.63 -2.35 -2.23
Operating Cash Flow Ratio
0.11 -6.23 -0.18 -1.67 -1.56
Short-Term Operating Cash Flow Coverage
0.00 0.00 -2.43 -401.38 0.00
Net Current Asset Value
¥ 1.53B¥ 165.17M¥ 1.44B¥ 2.56B¥ 3.74B
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.02 0.05 <0.01 0.02
Debt-to-Equity Ratio
0.01 0.02 0.08 0.01 0.02
Debt-to-Capital Ratio
0.01 0.02 0.07 0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.03 0.00 0.02
Financial Leverage Ratio
1.07 1.06 1.52 1.35 1.23
Debt Service Coverage Ratio
0.00 0.00 30.42 -18.90 0.00
Interest Coverage Ratio
0.00 0.00 -5.02K 0.00 0.00
Debt to Market Cap
0.00 0.00 0.08 <0.01 <0.01
Interest Debt Per Share
0.23 0.05 1.61 0.46 1.48
Net Debt to EBITDA
18.41 0.17 5.83 61.99 1.66
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%2325.83%47.25%
EBIT Margin
0.00%0.00%-7749.35%492.14%-2353.06%
EBITDA Margin
0.00%0.00%-7674.20%478.91%-2337.41%
Operating Profit Margin
0.00%0.00%-11395.09%3422.17%-2353.06%
Pretax Profit Margin
0.00%0.00%-32674.02%9097.35%-2649.26%
Net Profit Margin
0.00%0.00%-32674.02%23438.90%-2648.70%
Continuous Operations Profit Margin
0.00%0.00%-4609.38%23438.90%-2648.70%
Net Income Per EBT
97.49%44.73%100.00%257.65%99.98%
EBT Per EBIT
75.89%96.64%286.74%265.84%112.59%
Return on Assets (ROA)
-3.36%-76.29%-56.09%-61.55%-41.42%
Return on Equity (ROE)
-10.89%-80.66%-85.31%-83.35%-50.82%
Return on Capital Employed (ROCE)
-4.82%-183.80%-23.22%-10.72%-41.38%
Return on Invested Capital (ROIC)
-4.81%-183.06%-3.20%-10.70%-41.12%
Return on Tangible Assets
-3.36%-76.29%-56.45%-66.12%-43.60%
Earnings Yield
-3.54%-235.13%-130.65%-105.40%-10.20%
Efficiency Ratios
Receivables Turnover
0.00 0.00 2.45 -2.22 1.44
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 -0.34 10.87
Fixed Asset Turnover
0.00 0.00 0.81 -0.09 0.56
Asset Turnover
0.00 0.00 <0.01 >-0.01 0.02
Working Capital Turnover Ratio
0.00 0.00 <0.01 >-0.01 0.02
Cash Conversion Cycle
0.00 0.00 149.15 -1.24K 286.33
Days of Sales Outstanding
0.00 0.00 149.15 -164.17 252.74
Days of Inventory Outstanding
0.00 0.00 0.00 -1.08K 33.59
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
0.00 0.00 149.15 -1.24K 286.33
Cash Flow Ratios
Operating Cash Flow Per Share
0.13 -0.65 -0.88 -13.36 -12.82
Free Cash Flow Per Share
0.13 -0.65 -0.88 -13.92 -13.21
CapEx Per Share
<0.01 <0.01 <0.01 0.56 0.39
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.04 1.03
Dividend Paid and CapEx Coverage Ratio
320.63K -1.10K -443.27 -24.06 -32.51
Capital Expenditure Coverage Ratio
320.63K -1.10K -443.27 -24.06 -32.51
Operating Cash Flow Coverage Ratio
0.56 -13.57 -0.54 -28.80 -8.65
Operating Cash Flow to Sales Ratio
0.00 0.00 -16.24 103.09 -11.05
Free Cash Flow Yield
0.61%-76.39%-6.51%-48.28%-4.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-29.47 -0.43 -0.77 -0.95 -9.80
Price-to-Sales (P/S) Ratio
0.00 0.00 250.09 -222.39 259.67
Price-to-Book (P/B) Ratio
1.06 0.34 0.65 0.79 4.98
Price-to-Free Cash Flow (P/FCF) Ratio
169.91 -1.31 -15.36 -2.07 -22.79
Price-to-Operating Cash Flow Ratio
148.82 -1.31 -15.40 -2.16 -23.49
Price-to-Earnings Growth (PEG) Ratio
0.91 <0.01 0.02 0.90 0.02
Price-to-Fair Value
1.06 0.34 0.65 0.79 4.98
Enterprise Value Multiple
-7.29 -0.01 2.57 15.55 -9.45
Enterprise Value
538.90M 4.63M -885.73M -796.75M 19.45B
EV to EBITDA
-6.20 -0.01 2.57 15.55 -9.45
EV to Sales
0.00 0.00 -197.45 74.48 220.92
EV to Free Cash Flow
40.99 -0.09 12.13 0.69 -19.39
EV to Operating Cash Flow
40.99 -0.09 12.16 0.72 -19.98
Tangible Book Value Per Share
18.26 2.48 20.45 33.05 56.70
Shareholders’ Equity Per Share
18.26 2.48 20.65 36.46 60.42
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.86 >-0.01 <0.01
Revenue Per Share
0.00 0.00 0.05 -0.13 1.16
Net Income Per Share
-0.66 -2.00 -17.62 -30.39 -30.70
Tax Burden
0.97 0.45 1.00 2.58 1.00
Interest Burden
0.77 0.97 4.22 18.49 1.13
Research & Development to Revenue
0.00 0.00 25.49 -14.54 2.16
SG&A to Revenue
0.00 0.00 14.25 -76.26 10.22
Stock-Based Compensation to Revenue
0.00 0.00 2.29 -33.39 6.91
Income Quality
-0.09 1.06 0.35 0.44 0.42
Currency in CNY